These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28152588)

  • 1. A Sensitive in Vitro High-Throughput Screen To Identify Pan-filoviral Replication Inhibitors Targeting the VP35-NP Interface.
    Liu G; Nash PJ; Johnson B; Pietzsch C; Ilagan MX; Bukreyev A; Basler CF; Bowlin TL; Moir DT; Leung DW; Amarasinghe GK
    ACS Infect Dis; 2017 Mar; 3(3):190-198. PubMed ID: 28152588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.
    Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment.
    Landeras-Bueno S; Oda SI; Norris MJ; Li Salie Z; Guenaga J; Wyatt RT; Saphire EO
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of RNA aptamers targeting Ebola virus VP35.
    Binning JM; Wang T; Luthra P; Shabman RS; Borek DM; Liu G; Xu W; Leung DW; Basler CF; Amarasinghe GK
    Biochemistry; 2013 Nov; 52(47):8406-19. PubMed ID: 24067086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity.
    Brown CS; Lee MS; Leung DW; Wang T; Xu W; Luthra P; Anantpadma M; Shabman RS; Melito LM; MacMillan KS; Borek DM; Otwinowski Z; Ramanan P; Stubbs AJ; Peterson DS; Binning JM; Tonelli M; Olson MA; Davey RA; Ready JM; Basler CF; Amarasinghe GK
    J Mol Biol; 2014 May; 426(10):2045-58. PubMed ID: 24495995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
    Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription.
    Tigabu B; Ramanathan P; Ivanov A; Lin X; Ilinykh PA; Parry CS; Freiberg AN; Nekhai S; Bukreyev A
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40.
    Mirza MU; Ikram N
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions.
    Leung DW; Borek D; Luthra P; Binning JM; Anantpadma M; Liu G; Harvey IB; Su Z; Endlich-Frazier A; Pan J; Shabman RS; Chiu W; Davey RA; Otwinowski Z; Basler CF; Amarasinghe GK
    Cell Rep; 2015 Apr; 11(3):376-89. PubMed ID: 25865894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.
    Prins KC; Binning JM; Shabman RS; Leung DW; Amarasinghe GK; Basler CF
    J Virol; 2010 Oct; 84(20):10581-91. PubMed ID: 20686031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
    Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
    Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.
    Liu B; Dong S; Li G; Wang W; Liu X; Wang Y; Yang C; Rao Z; Guo Y
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle.
    Martin B; Canard B; Decroly E
    Antiviral Res; 2017 May; 141():48-61. PubMed ID: 28192094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
    Fanunza E; Frau A; Corona A; Tramontano E
    Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay.
    Daino GL; Frau A; Sanna C; Rigano D; Distinto S; Madau V; Esposito F; Fanunza E; Bianco G; Taglialatela-Scafati O; Zinzula L; Maccioni E; Corona A; Tramontano E
    Biochemistry; 2018 Nov; 57(44):6367-6378. PubMed ID: 30298725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of Ebola NP
    Wu C; Wagner ND; Moyle AB; Feng A; Sharma N; Stubbs SH; Donahue C; Davey RA; Gross ML; Leung DW; Amarasinghe GK
    J Mol Biol; 2023 Oct; 435(20):168241. PubMed ID: 37598728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a small molecule inhibitor of Ebola virus genome replication and transcription using in silico screening.
    Easton V; McPhillie M; Garcia-Dorival I; Barr JN; Edwards TA; Foster R; Fishwick C; Harris M
    Antiviral Res; 2018 Aug; 156():46-54. PubMed ID: 29870771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.
    Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus and host interactions critical for filoviral RNA synthesis as therapeutic targets.
    Basler CF; Krogan NJ; Leung DW; Amarasinghe GK
    Antiviral Res; 2019 Feb; 162():90-100. PubMed ID: 30550800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.